Thelansis

 Bronchiectasis is a chronic pulmonary ailment marked by persistent and enduring dilation of the bronchial airways and a weakening of the mucociliary transport mechanism, attributable to recurrent infections that facilitate bacterial invasion and mucus accumulation throughout the bronchial tree. Traditionally, antecedent respiratory infections, particularly in childhood, were considered the primary etiological factor. The causative factors encompass idiopathic, acquired, or infection-related origins. A predominant manifestation is an enduring cough with expectoration, characterized by a mixture of saliva and mucus expelled from the airways. Additional symptoms may encompass sinusitis, fatigue, dyspnea, wheezing, chest pain, and hemoptysis. Three pivotal mechanisms underlie the pathogenesis of bronchiectasis: recurrent infections, airway obstruction, and peribronchial fibrosis. Neutrophils assume a central role in airway inflammation, prompted by elevated concentrations of neutrophi...

 Bronchiectasis (Brong-ke-EK-ta-sis) is a condition where the airways become flabby and scarred due to damage. The airways are tubes that carry air in and out of your lungs. Damage to the walls of the airways usually is the cause of bronchiectasis. A lung infection may cause this damage. Severe pneumonia (nu-MO ne-ah), whooping cough or measles (uncommon in the United States due to vaccination), tuberculosis, and fungal infections are all examples of lung infections that can lead to bronchiectasis. Thelansis’s “Bronchiectasis Market Outlook, Epidemiology, Competitive Landscape , and Market Forecast Report – 2021 To 2032" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Bronchiectasis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and Chi...

  Bronchiectasis (Brong-ke-EK-ta-sis) is a condition in which damage to the airways causes them to widen and become flabby and scarred. The airways are tubes that carry air in and out of your lungs.   Etiology- Damage to the walls of the airways usually is the cause of bronchiectasis. A lung infection may cause this damage. Examples of lung infections that can lead to bronchiectasis include Severe pneumonia (nu-MO ne-ah), Whooping cough or measles (uncommon in the United States due to vaccination), Tuberculosis, Fungal infections.   The competitive landscape of Bronchiectasis includes country-specific approved as well as pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are being tracked and supplemented with analyst commentary. KOLs insights of Bronchiectasis across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiolo...